Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $759.09 | 39 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $172.55 | 11 | $0 (2022) |
| Lilly USA, LLC | $152.67 | 4 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $133.76 | 7 | $0 (2020) |
| Novo Nordisk Inc | $77.18 | 4 | $0 (2020) |
| GlaxoSmithKline, LLC. | $50.72 | 3 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $43.74 | 3 | $0 (2022) |
| Astellas Pharma US Inc | $40.56 | 2 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $23.17 | 1 | $0 (2017) |
| Allergan, Inc. | $21.76 | 1 | $0 (2020) |
| SHIELD THERAPEUTICS INC | $15.22 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $88.26 | 5 | Astellas Pharma US Inc ($40.56) |
| 2023 | $20.35 | 1 | Lilly USA, LLC ($20.35) |
| 2022 | $167.51 | 10 | Merck Sharp & Dohme LLC ($69.80) |
| 2021 | $63.54 | 4 | Merck Sharp & Dohme Corporation ($52.01) |
| 2020 | $75.92 | 4 | Novo Nordisk Inc ($22.63) |
| 2019 | $141.90 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($76.67) |
| 2018 | $151.36 | 4 | Lilly USA, LLC ($100.00) |
| 2017 | $50.25 | 3 | SANOFI-AVENTIS U.S. LLC ($23.17) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Biological | ||||||
| 09/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Biological | ||||||
| 08/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Diabetes | ||||||
| 07/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Inflammation | ||||||
| 05/09/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Hematology | ||||||
| 05/21/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Diabetes | ||||||
| 08/11/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Respiratory | ||||||
| 08/11/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: VACCINES | ||||||
| 06/23/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/03/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/02/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Neuroscience | ||||||
| 05/13/2022 | Merck Sharp & Dohme LLC | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/06/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: VACCINES | ||||||
| 03/11/2022 | GlaxoSmithKline, LLC. | PEDIARIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: VACCINES | ||||||
| 03/04/2022 | Merck Sharp & Dohme LLC | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/07/2022 | Merck Sharp & Dohme LLC | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/15/2021 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/17/2021 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/09/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.53 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/12/2021 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/18/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: NEUROSCIENCE | ||||||
| 03/11/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY XR | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: DIABETES | ||||||
| 02/26/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Diabetes | ||||||
| 01/31/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/11/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 17 | 17 | $540.14 | $304.22 |
| 2022 | 2 | 47 | 94 | $8,180 | $3,999 |
| 2021 | 6 | 118 | 173 | $10,611 | $6,975 |
| 2020 | 1 | 13 | 24 | $1,032 | $582.73 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 17 | 17 | $540.14 | $304.22 | 56.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 58 | $6,380 | $3,386 | 53.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 22 | 36 | $1,800 | $613.68 | 34.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 63 | $6,930 | $4,736 | 68.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 12 | 27 | $1,161 | $766.40 | 66.0% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 17 | 17 | $680.00 | $674.03 | 99.1% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 21 | 28 | $1,400 | $553.90 | 39.6% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 11 | 11 | $440.00 | $244.80 | 55.6% |
| 91301 | Sarscov2 vac 100mcg/0.5ml im | Office | 2021 | 24 | 27 | $0.27 | $0.27 | 100.0% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Office | 2020 | 13 | 24 | $1,032 | $582.73 | 56.5% |
About Dr. Sazia Setaruddin, MD
Dr. Sazia Setaruddin, MD is a Internal Medicine healthcare provider based in Richmond Hill, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649230038.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sazia Setaruddin, MD has received a total of $759.09 in payments from pharmaceutical and medical device companies, with $88.26 received in 2024. These payments were reported across 39 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($759.09).
As a Medicare-enrolled provider, Setaruddin has provided services to 195 Medicare beneficiaries, totaling 308 services with total Medicare billing of $11,861. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Richmond Hill, NY
- Active Since 03/28/2006
- Last Updated 02/12/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1649230038
Products in Payments
- JARDIANCE (Drug) $116.61
- TRULICITY (Drug) $100.00
- JANUVIA (Drug) $87.06
- STEGLATRO (Drug) $65.49
- Ozempic (Drug) $61.93
- Veozah (Drug) $40.56
- MOUNJARO (Drug) $37.89
- SHINGRIX (Biological) $32.90
- FARXIGA (Drug) $24.80
- TOUJEO (Drug) $23.17
- UBRELVY (Drug) $21.76
- VERQUVO (Drug) $20.00
- BREZTRI (Drug) $18.94
- PEDIARIX (Biological) $17.82
- TRADJENTA (Drug) $17.15
- Victoza (Drug) $15.25
- ACCRUFER (Drug) $15.22
- Otezla (Drug) $14.94
- EMGALITY (Drug) $14.78
- AFREZZA (Drug) $12.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Richmond Hill
Thomas Garner, M.d, M.D
Internal Medicine — Payments: $14,933
Dr. Douglas Perry, M.d, M.D
Internal Medicine — Payments: $10,239
Mrs. Rana Suleman, M.d, M.D
Internal Medicine — Payments: $7,998
Dr. Edward Hoffman, M.d, M.D
Internal Medicine — Payments: $6,744
Rita Jhaveri, Md, MD
Internal Medicine — Payments: $6,453
Dr. Wallace Holland, M.d, M.D
Internal Medicine — Payments: $3,068